CLINICAL_TRIALS
trial_result
· 2016-10-06
Clinical Trial Update: Ictal and Interictal Inflammatory Markers in Migraine [Phase 4]
Summary
Phase 4 clinical trial evaluating ictal and interictal inflammatory markers in migraine has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Johns Hopkins University | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2016-10-06